1. Home
  2. RELY vs RCUS Comparison

RELY vs RCUS Comparison

Compare RELY & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Remitly Global Inc.

RELY

Remitly Global Inc.

HOLD

Current Price

$13.01

Market Cap

3.0B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.03

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RELY
RCUS
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.8B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
RELY
RCUS
Price
$13.01
$21.03
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$24.90
$28.89
AVG Volume (30 Days)
3.1M
1.2M
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$1,544,865,000.00
$240,000,000.00
Revenue This Year
$30.78
N/A
Revenue Next Year
$18.57
N/A
P/E Ratio
$135.81
N/A
Revenue Growth
31.27
N/A
52 Week Low
$12.08
$6.50
52 Week High
$27.32
$26.40

Technical Indicators

Market Signals
Indicator
RELY
RCUS
Relative Strength Index (RSI) 40.47 42.95
Support Level $12.10 $19.91
Resistance Level $13.07 $22.29
Average True Range (ATR) 0.50 1.10
MACD -0.11 -0.19
Stochastic Oscillator 32.35 18.35

Price Performance

Historical Comparison
RELY
RCUS

About RELY Remitly Global Inc.

Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: